Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Engineering a high-affinity methyl-CpG-binding protein.

Helle F Jørgensen1, Karen Adie, Pascal Chaubert

  • 1The Wellcome Trust Centre for Cell Biology, University of Edinburgh, King's Buildings, Mayfield Road, Edinburgh EH9 3JR, UK. helle.jorgensen@csc.mrc.ac.uk

Nucleic Acids Research
|August 9, 2006
PubMed
Summary

Engineered poly-methyl-CpG-binding domain (MBD) proteins show enhanced DNA methylation detection. These novel reagents offer sensitive in vitro and in vivo analysis of CpG methylation levels.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dysfunction of a SET3-like complex underlies a family of related neurological disorders.

Nature communications·2026
Same author

TWIST1 drives endothelial-to-mesenchymal-transition to stabilize atherosclerotic plaques.

Nature communications·2026
Same author

Spatial transcriptomics reveals a key role of fibroblast-like vascular smooth muscle cells in human atherosclerotic cell crosstalk and stability.

European heart journal·2026
Same author

Defective vascular smooth muscle cell tafazzin impairs mitochondrial function and promotes atherosclerosis in preclinical models.

Nature communications·2025
Same author

Translational reading frame determines the pathogenicity of C-terminal frameshift deletions in MeCP2: an alternative therapeutic approach.

bioRxiv : the preprint server for biology·2025
Same author

Smooth muscle cells in atherosclerosis: essential but overlooked translational perspectives.

European heart journal·2025

Area of Science:

  • Molecular Biology
  • Epigenetics
  • Biochemistry

Background:

  • The methyl-CpG-binding domain (MBD) protein family, including MeCP2, MBD1, MBD2, and MBD4, recognizes methylated CpG sites in DNA.
  • MBD proteins are crucial for interpreting the epigenetic mark of DNA methylation.

Purpose of the Study:

  • To engineer a novel protein with significantly enhanced methyl-CpG binding affinity.
  • To evaluate the utility of engineered proteins for detecting DNA methylation in vitro and in vivo.

Main Methods:

  • Multimerization of the MBD domain of Mbd1 to create poly-MBD proteins.
  • In vitro binding assays to determine dissociation constants.
  • Cellular localization studies and in vivo reporter assays.

Related Experiment Videos

Main Results:

  • Engineered poly-MBD proteins exhibited >50-fold higher binding affinity for methylated CpG sites compared to monomeric MBDs.
  • Poly-MBD proteins successfully localized to methylated foci within cells.
  • Demonstrated in vivo delivery of functional domains to reporter constructs.

Conclusions:

  • Poly-MBD proteins represent sensitive reagents for detecting DNA methylation levels in isolated native DNA.
  • These engineered proteins are valuable for the cytological detection of chromosomal CpG methylation.